Serial 90577482
Live / Registered — Registered (as of 07 Feb 2023)
What this means for you
Registered since 07 Feb 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Feb 2029: the §8 declaration of use).
Record
- Serial number
- 90577482
- Registration number
- 6975363
- Mark type
- Design / logo
- Filed
- 13 Mar 2021
- Published for opposition
- 17 Aug 2021
- Registered
- 07 Feb 2023
- Next maintenance filing
- §8 declaration of use, due by 07 Feb 2029 (grace period to 07 Aug 2029)
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of infectious diseases
Owner
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
Prosecution history
- 07 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 04 Jan 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Jan 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Jul 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Jun 2022 — USE AMENDMENT FILED
- 30 Jun 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Jun 2022 — TEAS STATEMENT OF USE RECEIVED
- 19 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Feb 2022 — SOU EXTENSION 1 GRANTED
- 17 Feb 2022 — SOU EXTENSION 1 FILED
- 17 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 12 Oct 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Aug 2021 — PUBLISHED FOR OPPOSITION